Literature DB >> 31991009

The Loss of Profilin 1 Causes Early Onset Paget's Disease of Bone.

Federica Scotto di Carlo1, Laura Pazzaglia2, Teresa Esposito1,3, Fernando Gianfrancesco1.   

Abstract

Paget's disease of bone (PDB) is a late-onset disorder frequently caused by mutations in the SQSTM1 gene, leading to hyperactive osteoclasts and resulting in bone pain, deformities, and fractures. However, some more severe forms of PDB-negative for SQSTM1 mutations-have been described, in which the disease degenerates into bone cancers and shows a poor prognosis. Osteosarcoma is the most frequent and aggressive tumor arising in PDB (OS/PDB), with a 5-year survival rate almost nil, but the underlying molecular mechanism is unknown. Here, we investigated an extended pedigree with 11 individuals affected by early onset and polyostotic PDB, mainly interesting the appendicular skeleton. Interestingly, three members also developed secondary osteosarcoma. We performed exome sequencing and identified a 4-bp deletion in the PFN1 gene, resulting in the degradation of the mutant protein. Copy number screening on 218 PDB individuals of our biobank disclosed that four of them (~2%) carry a germline heterozygous deletion of PFN1. The identification of these subjects, who exhibit a particularly severe form of disease, emphasizes the diagnostic value of this genetic screening to identify PDB individuals predisposed to develop osteosarcoma. In fact, we detected allelic imbalance at PFN1 locus also in 8 of 14 (57%) sporadic OS/PDB, further proving its causative role. in vitro experiments also confirmed PFN1 involvement in this form of PDB. Indeed, CRISPR-Cas9-mediated Pfn1 knockout in pre-osteoclasts resulted into enhanced osteoclast differentiation and resorption, with the formation of large osteoclasts never described before in PDB. In addition, Pfn1 lacking pre-osteoblasts lost their differentiation capability and failed to efficiently mineralize bone. Moreover, they acquired features of malignant transformation, including loss of focal adhesions and increased invasion ability. In conclusion, these findings disclose PFN1 haploinsufficiency as the pathological mechanism in OS/PDB.
© 2020 American Society for Bone and Mineral Research. © 2020 American Society for Bone and Mineral Research.

Entities:  

Keywords:  CELL MODEL; CRISPR-Cas9 PRE-OSTEOBLAST CELL MODEL, CRISPR-Cas9 PRE-OSTEOCLAST; OSTEOSARCOMA; PAGET'S DISEASE OF BONE; PFN1

Mesh:

Substances:

Year:  2020        PMID: 31991009     DOI: 10.1002/jbmr.3964

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  11 in total

Review 1.  The Osteoclast Traces the Route to Bone Tumors and Metastases.

Authors:  Sharon Russo; Federica Scotto di Carlo; Fernando Gianfrancesco
Journal:  Front Cell Dev Biol       Date:  2022-05-13

Review 2.  Actin Remodeling Defects Leading to Autoinflammation and Immune Dysregulation.

Authors:  Riccardo Papa; Federica Penco; Stefano Volpi; Marco Gattorno
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

3.  PFN1 Gene Polymorphisms and the Bone Mineral Density Response to Alendronate Therapy in Postmenopausal Chinese Women with Low Bone Mass.

Authors:  Jiao Zhao; Li Liu; Shanshan Lv; Chun Wang; Hua Yue; Zhenlin Zhang
Journal:  Pharmgenomics Pers Med       Date:  2021-12-23

Review 4.  Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy.

Authors:  Manisha Korb; Allison Peck; Lindsay N Alfano; Kenneth I Berger; Meredith K James; Nupur Ghoshal; Elise Healzer; Claire Henchcliffe; Shaida Khan; Pradeep P A Mammen; Sujata Patel; Gerald Pfeffer; Stuart H Ralston; Bhaskar Roy; William W Seeley; Andrea Swenson; Tahseen Mozaffar; Conrad Weihl; Virginia Kimonis
Journal:  Orphanet J Rare Dis       Date:  2022-01-29       Impact factor: 4.123

5.  The Paget's disease of bone risk gene PML is a negative regulator of osteoclast differentiation and bone resorption.

Authors:  Sachin Wani; Anna Daroszewska; Donald M Salter; Rob J van 't Hof; Stuart H Ralston; Omar M E Albagha
Journal:  Dis Model Mech       Date:  2022-04-26       Impact factor: 5.732

6.  Juvenile Paget's Disease From Heterozygous Mutation of SP7 Encoding Osterix (Specificity Protein 7, Transcription Factor SP7).

Authors:  Michael P Whyte; Philippe M Campeau; William H McAlister; G David Roodman; Nori Kurihara; Angela Nenninger; Shenghui Duan; Gary S Gottesman; Vinieth N Bijanki; Homer Sedighi; Deborah J Veis; Steven Mumm
Journal:  Bone       Date:  2020-04-13       Impact factor: 4.398

7.  Targeted Inactivation of Rin3 Increases Trabecular Bone Mass by Reducing Bone Resorption and Favouring Bone Formation.

Authors:  Mahéva Vallet; Antonia Sophocleous; Anna E Törnqvist; Asim Azfer; Rob Van't Hof; Omar Me Albagha; Stuart H Ralston
Journal:  Calcif Tissue Int       Date:  2021-03-16       Impact factor: 4.333

8.  Mutations in Profilin 1 Cause Early-Onset Paget's Disease of Bone With Giant Cell Tumors.

Authors:  Zhe Wei; Shanshan Li; Xiaohui Tao; Guoying Zhu; Zhenkui Sun; Zhanying Wei; Qiong Jiao; Huizhen Zhang; Lin Chen; Baojie Li; Zhenlin Zhang; Hua Yue
Journal:  J Bone Miner Res       Date:  2021-03-10       Impact factor: 6.741

Review 9.  Genetic Predisposition to Solid Pediatric Cancers.

Authors:  Mario Capasso; Annalaura Montella; Matilde Tirelli; Teresa Maiorino; Sueva Cantalupo; Achille Iolascon
Journal:  Front Oncol       Date:  2020-10-28       Impact factor: 6.244

10.  Maackiain dampens osteoclastogenesis via attenuating RANKL-stimulated NF-κB signalling pathway and NFATc1 activity.

Authors:  Yuhao Liu; Weizai Zeng; Chao Ma; Ziyi Wang; Chao Wang; Shaobin Li; Wei He; Qingwen Zhang; Jiake Xu; Chi Zhou
Journal:  J Cell Mol Med       Date:  2020-09-16       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.